VEGFA and cancer: Nevertheless, additional functional evaluations are beneficial, with clinically relevant cargoes, such as cancer drug doxorubicin (DOX), or siRNA-s against therapeutically relevant targets, such as vascular endothelial growth factor (VEGF).